Perci Health, one of the UK’s most comprehensive virtual cancer clinics, has raised a total of £7.7 million in funding, following a recently closed £3 million investment round that doubled its original target.
As first reported by MedTech Insights, this latest backing includes £295,000 from Macmillan Cancer Support, reinforcing the charity’s strong confidence in Perci Health’s mission to transform how cancer care is delivered. New investors Guinness Ventures and Conduit Fund joined existing backers Octopus Ventures and 35 leading UK oncologists and cancer surgeons in supporting Perci’s human-first, tech-enabled care model.
Source: percihealth.com
Meeting the Needs of a Growing Cancer Population
Perci Health was founded by two female healthcare innovators to bridge long-standing gaps in cancer care, from prevention through recovery. Their AI-powered, multidisciplinary virtual clinic provides access to nurses, psychologists, physiotherapists, and dietitians, offering holistic support tailored to each patient’s journey. With cancer diagnoses rising—especially among working-age adults—and survivorship increasing, there’s a growing demand for long-term care that helps people return to work and live well. Perci’s platform addresses this by delivering personalised recovery plans that improve both clinical outcomes and cost efficiency.
Driving Change for Patients, Employers, and the System
The startup’s model not only benefits individuals but also supports employers, insurers, and healthcare systems. It enables earlier interventions, supports vocational rehabilitation, and contributes to national efforts to reduce economic inactivity caused by long-term illness. The UK government’s recent focus on keeping people in the workforce through health initiatives aligns closely with Perci Health’s work. Its partnerships with employers and insurers are expanding, making its support services more accessible across public and private sectors alike.
Empowering Women-Led Innovation in Healthcare
With 100% of its founders, 80% of its leadership team, and 60% of its executive board being women, Perci Health stands out as one of the few female-led healthtech scale-ups in the UK. Despite persistent underinvestment in female-led startups, Perci has consistently raised twice the national average deal size. Investors like Octopus Ventures and Conduit Fund praised the team’s combination of clinical excellence, tech scalability, and measurable impact—highlighting it as a rare, high-potential opportunity within healthcare.
Perci Health’s £7.7 million funding milestone marks a significant step toward redefining cancer care for the modern age. Its AI-powered, patient-centric model tackles long-ignored survivorship needs, supports economic recovery, and reflects a bold, inclusive vision for the future of healthcare. With a growing team of over 85 specialists, Perci Health is uniquely positioned to lead the shift toward a more compassionate, effective, and scalable approach to cancer support.
